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Risk stratification using clinical and historical variables
plus early low level exercise testing was performed in 141
patients with a first non-Q wave myocardial infarction . The
111 patients who performed the exercise test had a 3.6%
cardiac mortality rate in the first year compared with
13.3% in the 30 patients who could not exercise (p =
0.063), and a 1 year incidence rate of recurrent cardiac
events (cardiac death or recurrent nonfatal myocardial
infarction) of 10 .8% compared with 23.3% (p = 0.127) .
Patients who developed ischemia (ST depression or angina)
during the test had an increased incidence of cardiac events
in the year after the infarction (odds ratio >3, p < 0.05) .
When patients were subgrouped by the presence or
Although the in-hospital prognosis of patients with a first
non-Q wave myocardial infarction is better than that of
patients with a first Q wave infarction (1-3), the long-term
prognosis of the two groups is similar (4-7) . Patients with
non-Q wave infarction have been characterized as being at
high risk for recurrent infarction (3,8-12), and having a
subsequent poor prognosis (3,13) . This increased risk is
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absence of pulmonary congestion, the discriminatory value
of the exercise test was seen to reside primarily in the cohort
with pulmonary congestion . For example, ST depression
during exercise in this group identified patients with a 71 %
incidence of cardiac events in the year after the infarction
compared with 5.3% for those without ST depression (odds
ratio 45, p = 0.002) . In the patients without pulmonary
congestion, the exercise test had no discriminatory value .
It is concluded that early low level exercise testing has a
limited role after an uncomplicated non-Q wave infarction,
but is useful in patients with clinical markers of higher risk .
(J Am Coll Cardiol 1 8  ;14 31-7)
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thought to be due to a high incidence of a patent infarct-
related artery (4,8,14-16) with preservation of the myocar-
dium perfused by this artery, placing the patient at risk for
future ischemic events if the vessel reoccludes . The potential
for an early adverse outcome has encouraged an aggressive
diagnostic approach, with recommendations for coronary
angiography for all or most patients to identify those who
might benefit from early revascularization ( ,17,18) . Others
(4,1 ) have suggested that in the absence of symptoms,
coronary angiography is not needed .
We (20) and others (21,22) recently showed that risk
stratification that combines clinical features of the myocar-
dial infarction with results of exercise testing can identify
a large group of patients with a 1 year cardiac mortality
rate of <1% . We evaluated the cohort of the Multicenter
Post-Infarction Program (MPIP) with a first non-Q wave
infarction to determine the usefulness of clinical and his-
toric variables as well as the results of early low level
exercise testing to categorize patients at high and low risk of
having a new cardiac event in the years after the initial
infarction .
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503 Q-Wave
Infarctions
1417 Eligible Patients
1/7  - 12/80
867 CCU Survivors
1
65  First Mls
15 Indeterminate
208 History of
Prior MI
141 Non-Q-Wave
Infarctions
Figure 1 . Description of the study group as a subset of the larger
Multicenter Post-Infarction Program data base (23) . CCU = coro-
nary care unit ; MI = myocardial infarction .
Methods
Study patients . The details of the multicenter postinfarc-
tion risk stratification study have been described previously
(20,23) . Patients were eligible for enrollment if they were
<70 years of age, had evidence of myocardial infarction
(determined by two of the following   clinical symptoms or
electrocardiographic [ECG] or enzymatic criteria), were
discharged from the coronary care unit, had no other life-
threatening disease and were available for follow-up study .
Eight hundred sixty-seven patients were enrolled from
among 1,417 eligible patients at nine hospitals representing
four universities from January 1, 1 7  to December 31, 1 80
(Fig. 1) ; 65  patients gave no history of prior infarction .
After patients with left bundle branch block, Wolff-
Parkinson-White syndrome or electronically paced rhythm
were excluded, 141 patients had no diagnostic (>0 .03 s) Q
waves (or an R/S ratio > 1 in ECG lead V 2 ) and constitute the
group of patients with a first non-Q wave infarction (24) .
Informed consent was signed by all participants, and com-
mittees on human research at each institution approved the
protocol .
Follow-up. Each patient enrolled in the study was con-
tacted by a study nurse at 3, 6 and 12 months and yearly up
to 4 years (Database version 10) . Detailed review of any
rehospitalizations to identify cases of reinfarction was car-
ried out only for the first year of follow-up . A recurrent
infarction required hospital admission with cardiac pain and
elevated serum creatine kinase MB fraction. Procedure-
related infarctions were not included . A cardiac event was
defined as cardiac death or nonfatal infarction, whichever
occurred first. All deaths were reviewed and categorized by
an independent review committee (25) .
Exercise testing. An attempt was made to perform a low
level exercise test as soon as possible after the index
Table 1 . Cardiac Events in 141 Patients With a First
Non-Q Wave Infarction
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Within Within
Event 60 Days 1 Year
Cardiac death 10%)
8(6%)
Nonfatal reinfarction 6 (4%%) 13 ( %)
Coronary bypass surgery 8 (6%) 18 (13%)
Recurrent cardiac event 7 (5%) 1  (13%)
Recurrent cardiac event is defined as either nonfatal myocardial infarction
or cardiac death, whichever occurred first .
infarction in all patients . Patients did not undergo exercise
testing if they were unable to walk 100 feet on the treadmill,
had unstable angina or persistent pulmonary rales or conges-
tion or if their physician did not give permission . The test
was performed from the 5th to the 57th day after infarction ;
64% were tested by the 14th day . One patient had a new
infarction 6 days after the qualifying infarction and per-
formed an exercise test 2 weeks later. For data analysis, he
was considered to have not taken the exercise test . No
patient had lasting sequelae from the test .
The   min exercise protocol has been previously de-
scribed (20) . The test was terminated after completion of the
third stage (1 .7 miles/h and 10% grade, 5 METs) or before, if
required . ST segment displacement was measured 0 .06 s
after the J point in ECG leads aVF, V, and V s , and
significant depression was defined as
z2I mm horizontal or
downsloping displacement occurring during the exercise or
recovery period compared with the rest tracing . Patients
with ST segment depression at rest were not excluded .
Data analysis. Univariate analysis of selected variables
was performed using SAS (26), and differences were com-
pared by Fisher's exact test (two-tailed) . A proportional
hazards general linear model procedure (27) was performed
on the exercise and clinical variables separately and together
to determine if the addition of the exercise variables im-
proved the risk stratification for both end points .
Results
Cardiac events . There were 15 cardiac deaths (10.6%)
and 6 noncardiac deaths in the total follow-up period . The
distribution of cardiac events in the first 60 days and in the
first year in the patients with a first non-Q wave infarction is
presented in Table 1 . No patient underwent coronary angio-
plasty during the 2 to 4 year follow-up period ending in
December 1 82 .
Stratification by key clinical features (Table 2). The ab-
sence of pulmonary congestion on the X-ray film or rales
above the bases of the lungs on physical examination in the
coronary care unit identified a large group, comprising 75%
of all patients with a non-Q wave infarction, which had a low
cardiac mortality rate of 2 .8% in the first year and 6 .5% over
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Table 2 . Relation of Clinical and Historical Variables to End Points in 141
Patients
the entire follow-up period . The remaining 25% of patients
had evidence of pulmonary congestion and had a cardiac
mortality rate of 14 .7% in the first year and 23 .5% over the
follow-up period (odds ratio 6 .0, p = 0 .020 for the first year) .
Patients with pulmonary congestion also had a higher 1 year
cardiac event rate (26
.5%) than did those without pulmonary
congestion ( .4%, p = 0 .01 ) .
The 80% (111 of 141) of patients who underwent exercise
testing had a better survival experience as a group than did
the 20% (30 of 141) who did not . The cardiac mortality rate
in patients who did not undergo exercise testing was 13 .3%
in the first year and 23 .3% over the follow-up period com-
pared with 3.6% and 7 .2%, respectively, in those who did
(p = 0.063 first year, p = 0 .01  for entire follow-up period) .
Almost half of the cardiac deaths occurred in the 30 patients
who did not undergo exercise testing .
The relation of other variables to cardiac mortality and
recurrent infarction in the year after infarction is shown in
Table 2. A history of hypertension and the presence of sinus
tachycardia (heart rate > 0 beats/min) in the cardiac inten-
sive care unit were associated with an increase in the
incidence of cardiac death (p < 0.05) . A history of dyspnea,
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*Fisher's exact test (two-tailed) . ECG = electrocardiogram   LVH = left ventricular hypertrophy   NYHA = New
York Heart Association functional classification .
the presence of cardiac symptoms in the month before the
infarction and ST depression or left ventricular hypertrophy
on the qualifying ECG were also associated with an in-
creased incidence of cardiac death, with odds ratios all >2,
but p > 0.05 . Surprisingly, decreased ejection fraction was
not a useful indicator of outcome . A history of hypertension
or left ventricular hypertrophy on the qualifying ECG was
associated with an increased incidence of cardiac events in
the first year . Six (43%) of the 14 patients with left ventric-
ular hypertrophy on the ECG had a cardiac event during the
first year after the infarction .
Stratification by the results of the exercise test (Table 3) .
There were four cardiac deaths (3 .6%) and 12 cardiac events
(10.8%) in the year after the infarction in the patients who
performed a low level exercise t est . ST depression or angina,
the two variables reflecting the development of ischemia,
identified patients with more than three times the likelihood
of having a new cardiac event in the year after the infarction .
A heart rate > 120 beats/min during or after the exercise test
identified patients with more than twice the risk of cardiac
death as those without this response
. The inability to in-
crease the blood pressure to >110 mm Hg, which was of
I Year
Cardiac Event
I Year
Cardiac Death
No . %
Odds
Ratio
p Value* %
Odds
Ratio p Value*
History of hypertension 61 21 .3 3 .3 0 .024 11 .5
10 .2 0 .021
No hypertension 80
7 .5 1 .2
NYHA class Il-IV 50 20.0 2 .2 0
.123 10 .0 3 .2 0 .134
NYHA class 1  0 10.0 3 .3
History of dyspnea 41
1 .5 2 .0 0 .185   .8 2 .6 0 .231
No history of dyspnea 100 11 .0 4 .0
Ejection fraction <35% 23 13 .0 0 .  1 .000 4 .4 0 .7 1 .000
Ejection fraction >35% 10  14
.7 6 .4
LVH on ECG 14 42.  6 .5 0 .004 14 .3 3 .3 0 .186
No LVH on ECG 125 10.4 4 .8
Heart rate > 0 beats/min 22 18.2 1 .5 0 .4   18 .2
6 .4 0 .021
Heart rate < 0 beats/min 11  12 .6
3
.4
ST depression on ECG 2  20.7 1 .  0 .233 13 .8 4 .2 0 .060
No ST depression 10  11 .  3 .7
Pulmonary congestion 34 26.5 3 .5 0 .01  14 .7 6 .0 0 .020
No pulmonary congestion 107  .4 2 .8
No exercise test 30 23 .3 2 .5 0 .127 13 .3 4 .1 0 .063
Exercise test 111 10 .8 3 .6
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Table 3
. Exercise Features Versus Cardiac End Points at 1 Year
Follow-Up in l l l Patients Who Performed the Exercise Test
*p = 0 .026
; tp = 0
.04  . Angina = anginal discomfort during exercise or in
recovery ; BP = blood pressure ; VEDs = ventricular ectopic depolarizations .
such high discriminatory value in the total group of study
patients who performed the exercise test (20), was of no
value in the subgroup with a non-Q wave infarction ; how-
ever, only seven patients were in this category . Thus, the
exercise test in the unstratified patients with a non-Q wave
infarction could identify a group with >_8% risk of cardiac
death and a group with a mortality risk <4%. From the point
of view of new cardiac events, the exercise test in the
unstratified patients could identify a group with >20% risk of
cardiac events in the first year after infarction . No individual
variable, however, could identify a group with a <7% risk of
a cardiac event in the year after infarction
.
Stratification by combined clinical and exercise variables
.
"Prestratifying" the 111 patients who underwent exercise
testing according to the presence or absence of pulmonary
congestion permitted the clear separation of the study pa-
tients into two groups at very different risk for subsequent
cardiac events or cardiac death. In the 85 patients with no
pulmonary congestion or rales in the coronary care unit who
performed the exercise test, there was one cardiac death and
six recurrent cardiac events (Fig . 2) in the year after infarc-
tion . In contrast, in the 26 patients in the exercise group with
evidence of left ventricular dysfunction, the 1 year risk of
cardiac death was 23%. The value of exercise test variables
to identify patients at risk for recurrent infarction or cardiac
death was evaluated separately in the Ill patients according
to whether or not they had pulmonary congestion (Table 4) .
In the pulmonary congestion subgroup, cardiac death was
more likely in patients who developed ST depression with
exercise, an excessively high heart rate or ventricular ec-
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topic depolarizations, although p was > 0 .1 for all (a fact that
may reflect the small number of patients) . The exercise
variables-inability to complete the low level exercise pro-
tocol, development of a heart rate >120 beats/min and,
especially, the variables reflecting cardiac ischemia (ST
depression and angina)-were associated with increased
incidence of cardiac events . The demonstration of ischemia
was especially discriminating   five of the six patients with
pulmonary congestion who had a cardiac event in the first
year had ST depression on the exercise test. There was a
71
.4% incidence of a cardiac event in the year after infarc-
tion in those patients with pulmonary congestion who dem-
onstrated ST depression on the low level exercise test
compared with a 5 .3% incidence in those without pulmonary
congestion (odds ratio 45, p = 0 .002) .
A similar evaluation of the subgroup of patients who did
not have pulmonary congestion or rales, however, identified
only the development of angina during exercise as a clinical
predictor, with an odds ratio of 2
.5 for a cardiac event .
However, the number of events was very small
; only 15
patients (l8%) developed angina, and only 2 of these patients
had a cardiac event . No other variables showed discrimina-
tory value for either cardiac events or cardiac death in the
year after infarction . In large part, this result was due to the
fact that patients without pulmonary congestion who can
exercise are an extremely low risk group, with few "pos-
itive" low level exercise tests by any criteria and fewer
cardiac events in the first year after infarction
.
A proportional hazards analysis (27) performed in those
patients who underwent exercise testing demonstrated that
the addition of the exercise variables to the clinical variables
did not significantly improve the model when either cardiac
death or cardiac events were used as end points .
Prognostic stratification using both clinical and exercise
variables is shown in Figure 2 . The initial separation by the
presence or absence of pulmonary congestion and a second
clinical stratification based on the ability to take the exercise
test separate a group at high risk for subsequent cardiac
events or death from a group at much lower risk . In those
patients without pulmonary congestion, the exercise test
variables were clearly of no value . In the patients with
pulmonary congestion who exercised, a positive test (that is,
inability to complete the protocol or development of ST
depression) identified patients at high risk of cardiac death or
a cardiac event within 1 year, but a good performance on the
test gave no assurance that the patient would remain free of
events in the year after the infarction .
Discussion
Recent studies (1,3,4,10,16,28,2 ) have shown that the
amount of myocardial damage after an initial non-Q wave
infarction is, on average, less than that after an initial Q
wave infarction
. However, because patients with a non-Q
Exercise Feature
No .
Cardiac
Event
(%)
Odds
Ratio
Cardiac
Death
(%)
Odds
Ratio
Duration <  min 45 11 .1
1 .1 4 .4 1 .5
Duration =   min
66 10.6 3 .0
ST depression ? 1 mm 25 24.0 4 .2* 8 .0 3 .7
No ST depression
86 7 .0 2 .3
Angina with exercise
21 23 .8 3 .7t   .5 4.6
No angina  0 7 .8
2
.2
Heart rate > 120 beats/min
37 10
.8
1 .0 5 .4 2 .1
Heart rate <120 beats/min
74 10 .8 2 .7
Max BP <_110 mm Hg 7 14
.3 1 .4 0 .0
Max BP >110 mm Hg
102 10 .8 3 . 
Any VEDs
a8
6 .2 0 .4 4 .2 1 .3
No VEDs
63 4.3 3 .2
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wave infarction have a high rate of reinfarction ( ,30,31), the
initial prognostic advantage over Q wave infarction is soon
lost . We and others have shown that clinical features of
infarction alone (31-35) or combined with low level exercise
testing (20-22,36) can identify those at high risk of early
reinfarction and death, so that invasive testing can be
applied selectively (Tables 2 and 4) .
Follow-up course after non-Q wave infarction . The data
presented here attempt to define the role of early low level
exercise testing in this stratification process in patients with
non-Q wave infarction . Early natural history studies (37,38)
of patients after myocardial infarction showed that the
majority of deaths in survivors of infarction occur in the first
4 to 6 months after hospital discharge . Exercise testing
before discharge was advocated to identify patients at risk
before the event (3 ) . More recent studies (40) have shown
that the patients at highest risk for early death can be
identified from clinical features of the infarction only, be-
cause the patients at highest risk are not permitted to
exercise (20-22,36). In the present group of patients with a
first non-Q wave infarction, we were able to identify a large
cohort at very low risk for cardiac death using a clinical
stratification based on the absence of signs of left ventricular
dysfunction (pulmonary congestion) and the ability to per-
form the exercise test . Although there was a 7% incidence of
cardiac events in the year after the infarction in these
KRONE ET AL .
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Figure 2 . Prognostic stratification by presence of pulmonary
(Puim .) congestion (presence or absence of pulmonary congestion
on admitting chest X-ray film or pulmonary rales above the bases on
examination in the coronary care unit), ability to perform the
exercise test and the exercise variables (ability to complete the low
level protocol and ST depression with exercise) . End point = 1 year
cardiac events (cardiac death or recurrent infarction, or both) . I ST
= ST segment depression ; other abbreviations as in Figure 1 .
patients, only two patients who exercised had a recurrent
cardiac event in the first 60 days, and in one patient the test
was normal . Low level "early" exercise testing did not
identify patients at higher or lower risk for either recurrent
infarction or cardiac death, in large part because of the low
event rate in this "pre stratified" group (22) .
Low level exercise testing, however, had an important
role in managing patients with pulmonary congestion-a
relatively high risk subgroup . In these patients, ischemia or
poor performance on the exercise test was associated with a
very high incidence of cardiac death or recurrent infarction
(Table 4). However, even those with a negative test still had
a 1 year cardiac mortality rate of >5% .
Clinical role of low level early exercise testing . The data
suggest that low level predischarge exercise testing should
be applied selectively to patients surviving a non-Q wave
infarction on the basis of results of clinical risk stratification .
141 Non-Q-Wave MIs
8 Cardiac Deaths (6%)
1  Cardiac Events (13.5%)
34 Patients with Puim .
Congestion
or Rates
107 Patients
Congestion
3 Cardiac Deaths
10 Cardiac Events
with no Pulm .
or Rates
(3%)
( %)
5 Cardiac Deaths (15%)
  Cardiac Events (26%)
/\
/\
8 Non-exercising
Patients
2 6
Exercising
Patients
Cardiac Deaths
Cardiac Events
(12%)
(23%)
22 Non-exercising
Patients
2 Cardiac Deaths ( %)
4 Cardiac Events (18%)
85 Exercising
Patients
I
Cardiac Death (1%)
6 Cardiac Events (7 /6)
2 Cardiac Deaths (25%)
3 Cardiac Events (38%)
3
6
	
/\
  Patients
Duration c   min .
1 7 Patients
Duration =   min .
36 Patients
Duration c   min.
4  Patients
Duration =   min .
I Cardiac Death (11%)
2 Cardiac Deaths (12%) 1 Cardiac Death (3%) 0 Cardiac Deaths (0%)
3 Cardiac Events (33%) 3 Cardiac Events (18%)
2 Cardiac Events (6%)
4 Cardiac Events (8%)
7 Patients
1  Patients 18 Patients 67 Patients
1 ST, >1 mm No 1 ST 1 ST, > 1 mm No I ST
2 Cardiac Deaths (2 %) 1 Cardiac Death (5%) 0 Cardiac Deaths (0%) 1 Cardiac Death (1%)
5 Cardiac Events (71%) I
Cardiac Event (5%)
1 Cardiac Event (6%) 5 Cardiac Events (7%)
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Table 4 . Exercise Features in 85 Patients With Pulmonary
Congestion Versus End Points at I Year Follow-up
*p = 0 .002 (two-tailed Fisher exact test) . Abbreviations as in Table 3 .
The low level predischarge exercise test has an important
role in stable patients with clinical indicators of high risk,
specifically, congestion on chest X-ray study or rales above
the lung bases . In these patients, evidence of ischemia (ST
depression or angina) or poor exercise tolerance (poor
endurance or excessive heart rate response) identifies pa-
tients at a >30% risk of a cardiac event in the first year, so
that early angiography can be advocated . The data also
suggest that patients in this group who do not demonstrate
these findings on the exercise test have a better prognosis
and can be discharged, perhaps to have a more sensitive test
such as a thallium perfusion scan performed during maximal
exercise soon after discharge (41-45) .
The low level exercise test is of minimal value in patients
in stable condition in the low risk group, so that these
patients can be discharged early without undergoing this test
(46) . Additional strategies of risk stratification to identify
better the 7% of patients with a new cardiac event in the first
year after infarction, perhaps utilizing more sensitive testing
with symptom-limited exercise testing and thallium perfu-
sion scanning, need to be evaluated and validated in this
group (41,43-45) . The impact of pharmacologic therapy in
further lowering the risk in these patients also needs to be
considered in designing such a strategy (47,48) .
Of course, these recommendations are based on a "post
hoc" data analysis
. The conclusions of any retrospective
subgroup analysis at best can only be considered explor-
atory
. Validation of these findings by comparison with other
databases or by a prospective study is required before they
can be accepted without reservation .
We thank Cindy Apkter, MS and David Krone for statistical computations,
Elizabeth Hahn for additional help with the database and Arthur J . Moss, MD
for his review of the manuscript .
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Conclusions . Patients with a first non-Q wave infarction
at high and low risk for subsequent cardiac events can be
identified from clinical information alone . In patients in
stable condition with pulmonary congestion, the early low
level exercise test can identify a group at an especially high
risk, but patients with a normal exercise test still have a >5%
cardiac event rate in the year after infarction . In patients in
stable condition without pulmonary congestion who can
exercise, early low level exercise testing provides minimal
additional clinically useful information . More strategies are
needed for risk stratification in patients without pulmonary
congestion and in those with pulmonary congestion who
have a normal exercise test .
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